Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Trava Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Trava Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 167 · Grade C

Trava Health

Visit Trava Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 70 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Trava Health a bad call — it's best for readers considering a quarterly medication package who will obtain the complete charge, formulation and pharmacy assignment before ordering. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
66
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
69
Track Record
88
68
CoreAge RxBrief Score 94 · 70Trava Health

Price, coverage & the tracker

CoreAge RxTrava Health
Brief Score94/100 (A)70/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm quarterly total

Advertised $89/mo equivalent requires a quarterly package. Full payment, supplied weeks and formulation need confirmation.

Full price details

Current semaglutide formulation and complete quote unknown; $89/month equivalent requires a quarterly package; earlier listing: From $119/mo (starting dose, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm quarterly total

Advertised $147/mo equivalent requires a quarterly package. Full payment, supplied weeks and formulation need confirmation.

Full price details

Current tirzepatide formulation and complete quote unknown; $147/month equivalent requires a quarterly package; earlier listing: From $198/mo (starting dose, compounded)

CoverageUS only; restrictions by state, confirmed at intakeFAQ advertises all 50 states; confirm medication- and pharmacy-specific eligibility
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Trava Health: The $89 semaglutide and $147 tirzepatide figures require quarterly packages. Complete charges and formulations remain unconfirmed; older medication dates are retained.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.